AMERIPRISE FINANCIAL INC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$5,672,363
-7.4%
60,576
-11.7%
0.00%0.0%
Q2 2023$6,124,233
+5.7%
68,619
+27.0%
0.00%0.0%
Q1 2023$5,793,403
-12.4%
54,033
-0.2%
0.00%0.0%
Q4 2022$6,612,000
+17.5%
54,136
-0.6%
0.00%0.0%
Q3 2022$5,625,000
+20.6%
54,467
+8.6%
0.00%0.0%
Q2 2022$4,663,000
-23.3%
50,165
-3.2%
0.00%0.0%
Q1 2022$6,080,000
-7.0%
51,809
+6.7%
0.00%0.0%
Q4 2021$6,535,000
-19.9%
48,577
-5.1%
0.00%
-33.3%
Q3 2021$8,159,000
+18.1%
51,187
-2.6%
0.00%
+50.0%
Q2 2021$6,910,000
+11.6%
52,531
+9.4%
0.00%0.0%
Q1 2021$6,191,000
-47.1%
48,037
-31.5%
0.00%
-50.0%
Q4 2020$11,700,000
+4.1%
70,156
-3.7%
0.00%
-20.0%
Q3 2020$11,241,000
+3.0%
72,830
-1.3%
0.01%0.0%
Q2 2020$10,909,000
+31.4%
73,763
+0.1%
0.01%
+25.0%
Q1 2020$8,299,000
-39.4%
73,702
-25.1%
0.00%
-33.3%
Q4 2019$13,694,000
+44.8%
98,433
+0.2%
0.01%
+50.0%
Q3 2019$9,458,000
-22.5%
98,193
-7.4%
0.00%
-20.0%
Q2 2019$12,209,000
+63.2%
106,031
+66.8%
0.01%
+66.7%
Q1 2019$7,481,00063,5830.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2020
NameSharesValueWeighting ↓
RA Capital Management 11,225,357$1,001,863,11218.92%
Q Global Advisors, LLC 195,000$17,40412.55%
Sofinnova Investments, Inc. 754,032$67,297,3564.41%
Avoro Capital Advisors LLC 3,580,555$319,564,5344.34%
Finepoint Capital LP 139,772$12,474,6514.32%
Spyglass Capital Management LLC 657,853$58,713,3804.24%
Saturn V Capital Management LP 78,442$7,000,9483.88%
DAFNA Capital Management LLC 135,212$12,067,6713.30%
ARS Investment Partners, LLC 289,860$25,870,0053.02%
Ghost Tree Capital, LLC 100,000$8,925,0002.95%
View complete list of ASCENDIS PHARMA A/S shareholders